Skip to content

Comparison of ozone therapy and honey therapy on diabetic foot ulcers

Comparison between the effect of ozone therapy and honey therapy on diabetic foot ulcers

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130317012830N32
Enrollment
70
Registered
2018-02-28
Start date
2017-10-23
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Ozone therapy group: In this group, patients receive a single intravenous line after receiving routine therapies and 50 cc of blood is taken from the patient and combined with 50 cc of

Sponsors

Research Deputy of Bushehr University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1.diabetic foot ulcers graid 3-4. 2.Patients admitted in the internal ward. 3.Patients aged 20-75 years old. 4.Patients undergo routine treatment.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1.Patients who receive another treatment at the same time. 2.Patients who did not complete the course of treatment and were not regular. 3.Patients who require surgical debridement . 4.Patients who die during the study. 5.Patients who are not satisfied with the continuation of treatment. 6.The history of deep vein thrombosis. 7.There is a history of hemorrhage from the foot ulcer.

Design outcomes

Primary

MeasureTime frame
Diabetic foot ulcer. Timepoint: Every 3 to 7 days, once a week, 4 weeks in the honey therapy group, 2 times a week for 4 weeks in the ozone therapy group. Method of measurement: Determine the wound gradient based on the PEDIS table and measure the wound using a graded ruler.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFaezeh Jahanpour

Bushehr University Of Medical Sciences

F_jahanpour@yahoo.com+98 77 1455 0187

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026